These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
337 related items for PubMed ID: 17706209
1. Use of the levonorgestrel-releasing intrauterine system in breast cancer patients. Trinh XB, Tjalma WA, Makar AP, Buytaert G, Weyler J, van Dam PA. Fertil Steril; 2008 Jul; 90(1):17-22. PubMed ID: 17706209 [Abstract] [Full Text] [Related]
2. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders. Lukes AS, Reardon B, Arepally G. Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734 [Abstract] [Full Text] [Related]
3. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Shaamash AH, Sayed GH, Hussien MM, Shaaban MM. Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660 [Abstract] [Full Text] [Related]
4. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system. de Jonge ET, Yigit R, Molenberghs G, Straetmans D, Ombelet W. Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176 [Abstract] [Full Text] [Related]
5. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis]. Deng S, Lang JH, Leng JH, Liu ZF, Sun DW, Zhu L. Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919 [Abstract] [Full Text] [Related]
6. Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system. Heikinheimo O, Inki P, Kunz M, Gemzell-Danielsson K. Hum Reprod; 2010 Jun; 25(6):1423-7. PubMed ID: 20378611 [Abstract] [Full Text] [Related]
7. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study. Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, Gupta JK. Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693 [Abstract] [Full Text] [Related]
8. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer. Neven P, Amant F, Poppe W, Van den Broecke R. Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759 [No Abstract] [Full Text] [Related]
9. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Petta CA, Ferriani RA, Abrao MS, Hassan D, Rosa E Silva JC, Podgaec S, Bahamondes L. Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607 [Abstract] [Full Text] [Related]
10. The Femilis LNG-IUS: contraceptive performance-an interim analysis. Wildemeersch D, Janssens D, Andrade A. Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705 [Abstract] [Full Text] [Related]
11. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Chin J, Konje JC, Hickey M. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007245. PubMed ID: 19821400 [Abstract] [Full Text] [Related]
12. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system. Bahamondes MV, Monteiro I, Castro S, Espejo-Arce X, Bahamondes L. Hum Reprod; 2010 May 07; 25(5):1158-64. PubMed ID: 20185512 [Abstract] [Full Text] [Related]
13. Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis. Fu Y, Zhuang Z. Int J Clin Exp Pathol; 2014 May 07; 7(10):6419-29. PubMed ID: 25400720 [Abstract] [Full Text] [Related]
14. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system. Wildemeersch D, Rowe PJ. Contraception; 2005 Jun 07; 71(6):470-3. PubMed ID: 15914139 [Abstract] [Full Text] [Related]
15. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey. Römer T, Linsberger D. Eur J Contracept Reprod Health Care; 2009 Dec 07; 14(6):391-8. PubMed ID: 19929641 [Abstract] [Full Text] [Related]
16. Subject and clinician experience with the levonorgestrel-releasing intrauterine system. Jensen JT, Nelson AL, Costales AC. Contraception; 2008 Jan 07; 77(1):22-9. PubMed ID: 18082662 [Abstract] [Full Text] [Related]
17. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems. Wildemeersch D, Janssens D, Vrijens M, Weyers S. Contraception; 2005 Jun 07; 71(6):465-9. PubMed ID: 15914138 [Abstract] [Full Text] [Related]
18. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. Chan SS, Tam WH, Yeo W, Yu MM, Ng DP, Wong AW, Kwan WH, Yuen PM. BJOG; 2007 Dec 07; 114(12):1510-5. PubMed ID: 17995495 [Abstract] [Full Text] [Related]
19. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. Reid PC, Virtanen-Kari S. BJOG; 2005 Aug 07; 112(8):1121-5. PubMed ID: 16045528 [Abstract] [Full Text] [Related]
20. Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis. Conz L, Mota BS, Bahamondes L, Teixeira Dória M, Françoise Mauricette Derchain S, Rieira R, Sarian LO. Acta Obstet Gynecol Scand; 2020 Aug 07; 99(8):970-982. PubMed ID: 31990981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]